Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services,

more »

... torate for Information Operations and Reports (0704-0188), 1215 Jefferson Davis Highway, Suite 1204, Arlington, VA 22202-4302. Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to any penalty for failing to comply with a collection of information if it does not display a currently valid OMB control number. PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. SUPPLEMENTARY NOTES ABSTRACT Purpose: To develop a light-activated technology with the potential to decrease vision loss and ocular complications in warfighters sustaining penetrating eye injuries. Scope: To establish, in ex vitro and in vivo animal models, the treatment parameters for sealing corneal and scleral penetrating wounds and to close lacerations in thin (eyelid-like) skin. To design and evaluate a prototype light delivery device. Major findings: We established that bonding amniotic membrane over penetrating cornea and scleral wounds produced immediate, water-tight seals that withstood an intraocular pressure of 350 mm Hg. We closed lacerations in eyelid-like skin with the dye + light treatment, which showed less inflammation than after sutured closure. A prototype light delivery system was designed, constructed and tested to deliver retina-safe light levels while providing light levels sufficient for sealing amniotic membrane over corneal wounds. Studies demonstrated that thermal damage to the iris is not a concern during these repair treatments.